TY - JOUR AU - Rakuomi, Vivian AU - Okalebo, Faith AU - Ndwigah, Stanley AU - Mbugua, Levi PY - 2017 DA - 2017/07/14 TI - Cost effectiveness of pre-referral antimalarial treatment in severe malaria among children in sub-Saharan Africa JO - Cost Effectiveness and Resource Allocation SP - 14 VL - 15 IS - 1 AB - In 2013, 78% of malaria deaths occurred in children aged 5 years and below, in sub-Saharan Africa. Treatment of severe malaria requires a health facility with inpatient care. However, in most sub-Sahara African countries, access to health facilities is a major problem. Pre-referral antimalarial treatments aim to delay the progress of severe malaria as patients seek to access health facilities. Rectal artesunate can be administered in the community as a pre-referral treatment in rural hard-to-reach areas. In Kenya, though pre-referral rectal artesunate has been included in the National Guidelines for pre-referral treatment, it is yet to be implemented in the public healthcare system. It is important, therefore, to establish its cost-utility compared to current parenteral treatments. This study evaluated the cost-utility of provision of pre-referral treatments by community health workers compared to similar services at a primary health facility. SN - 1478-7547 UR - https://doi.org/10.1186/s12962-017-0076-5 DO - 10.1186/s12962-017-0076-5 ID - Rakuomi2017 ER -